Education
About Us
Working with TipRanks
Follow Us
Marc Belsky Insider Profile
4 Followers
Marc Belsky, SVP & CFO at Five Prime Therapeutics, holds 17.38K shares in Kezar Life Sciences (Ticker: KZR), holds 60.47K shares in Five Prime Therapeutics (Ticker: FPRX). Most recently, Marc Belsky Bought ― shares of Kezar Life Sciences on Feb 05, 2020 for an estimated value of 40.00K.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+35.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Marc Belsky holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 13, 2019 - Nov 13, 2020
Return:+103.30%
The most profitable trade made by Marc Belsky
Marc Belsky's Trading History
Five Prime Therapeutics
Feb 28, 2018
―
Uninformative Buy
―
$2.30M
Kezar Life Sciences
Feb 05, 2020
CFO
Informative Buy
40.00K
$106.04K
List of latest transactions for each holding click on a transaction to see Marc Belsky's performance on stock
You May Also Like
Marc Belsky insider profile FAQ
What is the percentage of profitable transactions made by Marc Belsky?
The percentage of profitable transactions made by Marc Belsky is 60%.
What is the average return per transaction made by Marc Belsky?
The average return per transaction made by Marc Belsky is 35.80%.
What stocks does Marc Belsky hold?
Marc Belsky holds: FPRX, KZR stocks.
What was Marc Belsky’s latest transaction?
Marc Belsky latest transaction was an Informative Buy of $40.00K.
What was Marc Belsky's most profitable transaction?
Marc Belsky’s most profitable transaction was an Informative Buy of KZR stock on November 13, 2019. The return on the trade was 103.30%.
What is Marc Belsky's role in Five Prime Therapeutics?
Marc Belsky's role in Five Prime Therapeutics is SVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.